Altogether, our results have confirmed the role of TASK-3 in proliferation and highlight this channel as a potential target for the development of specific inhibitors that can be used in the treatment of triple-negative breast cancers. This evidence concerns the gene KCNK9 and triple-negative breast carcinoma.